These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28566683)

  • 1. Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.
    Madan-Lala R; Pradhan P; Roy K
    Sci Rep; 2017 May; 7(1):2530. PubMed ID: 28566683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity.
    Short KK; Miller SM; Walsh L; Cybulski V; Bazin H; Evans JT; Burkhart D
    J Control Release; 2019 Dec; 315():186-196. PubMed ID: 31654684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory effects of Toll-like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris.
    Gao C; Liu M; Xin Y; Zeng Y; Yang H; Fan X; Zhao C; Zhang B; Zhang L; Li JJ; Zhao M; Wang Z; Lu Q
    Clin Transl Med; 2024 Jul; 14(7):e1765. PubMed ID: 39031979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders.
    Thomas S; Pak J; Doss-Gollin S; Ryff K; Beijnen E; Pedersen GK; Christensen D; Levy O; van Haren SD
    J Mol Biol; 2024 Feb; 436(4):168446. PubMed ID: 38242283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directing the immune system with chemical compounds.
    Mancini RJ; Stutts L; Ryu KA; Tom JK; Esser-Kahn AP
    ACS Chem Biol; 2014 May; 9(5):1075-85. PubMed ID: 24690004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses.
    Shinde P; Bharat V; Rodriguez-Oquendo A; Zhou B; Vella AT
    Expert Opin Biol Ther; 2018 Oct; 18(10):1073-1083. PubMed ID: 30169979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.
    Netea MG; Van der Meer JW; Sutmuller RP; Adema GJ; Kullberg BJ
    Antimicrob Agents Chemother; 2005 Oct; 49(10):3991-6. PubMed ID: 16189071
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward precision adjuvants: optimizing science and safety.
    Nanishi E; Dowling DJ; Levy O
    Curr Opin Pediatr; 2020 Feb; 32(1):125-138. PubMed ID: 31904601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR-based immune adjuvants.
    Steinhagen F; Kinjo T; Bode C; Klinman DM
    Vaccine; 2011 Apr; 29(17):3341-55. PubMed ID: 20713100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like Receptor Agonist Conjugation: A Chemical Perspective.
    Ignacio BJ; Albin TJ; Esser-Kahn AP; Verdoes M
    Bioconjug Chem; 2018 Mar; 29(3):587-603. PubMed ID: 29378134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor agonists: are they good adjuvants?
    Gnjatic S; Sawhney NB; Bhardwaj N
    Cancer J; 2010; 16(4):382-91. PubMed ID: 20693851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Mediated Insertion of Toll-Like Receptor (TLR) Ligands for Facile Immune Cell Engineering.
    Zhang MH; Slaby EM; Stephanie G; Yu C; Watts DM; Liu H; Szeto GL
    Front Immunol; 2020; 11():560. PubMed ID: 32425924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision nanoscale patterning of TLR ligands for improved cancer immunotherapy.
    Tseng CY; Murtada F; Chou LYT
    Cell Rep Methods; 2024 May; 4(5):100782. PubMed ID: 38772343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of polymer-based particulate vaccine adjuvants.
    Huete-Carrasco J; Lynch RI; Ward RW; Lavelle EC
    Eur J Immunol; 2024 Feb; 54(2):e2350512. PubMed ID: 37994660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation.
    Acharya AP; Carstens MR; Lewis JS; Dolgova N; Xia CQ; Clare-Salzler MJ; Keselowsky BG
    J Mater Chem B; 2016 Mar; 4(9):1672-1685. PubMed ID: 26985393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Make it a combo.
    Reed SG; Carter D
    Sci Transl Med; 2024 Jul; 16(758):eadq5644. PubMed ID: 39083583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant.
    Euliano EM; Pogostin BH; Agrawal A; Yu MH; Baryakova TH; Graf TP; Hartgerink JD; McHugh KJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF6-IRF5 kinetics, TRIF, and biophysical factors drive synergistic innate responses to particle-mediated MPLA-CpG co-presentation.
    Pradhan P; Toy R; Jhita N; Atalis A; Pandey B; Beach A; Blanchard EL; Moore SG; Gaul DA; Santangelo PJ; Shayakhmetov DM; Roy K
    Sci Adv; 2021 Jan; 7(3):. PubMed ID: 33523878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zebrafish as a potential model for vaccine and adjuvant development.
    Hotez PJ; Bottazzi ME; Islam NY; Lee J; Pollet J; Poveda C; Strych U; Thimmiraju SR; Uzcategui NL; Versteeg L; Gorelick D
    Expert Rev Vaccines; 2024; 23(1):535-545. PubMed ID: 38664959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.
    Shakya AK; Nandakumar KS
    J R Soc Interface; 2013 Feb; 10(79):20120536. PubMed ID: 23173193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.